XNASHSIC
Market cap8.69bUSD
Jan 10, Last price
69.67USD
1D
-1.96%
1Q
-1.22%
Jan 2017
-8.16%
Name
Henry Schein Inc
Chart & Performance
Profile
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 12,339,000 -2.44% | 12,647,000 1.98% | |||||||
Cost of revenue | 8,478,000 | 8,816,000 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 3,861,000 | 3,831,000 | |||||||
NOPBT Margin | 31.29% | 30.29% | |||||||
Operating Taxes | 120,000 | 170,000 | |||||||
Tax Rate | 3.11% | 4.44% | |||||||
NOPAT | 3,741,000 | 3,661,000 | |||||||
Net income | 416,000 -22.68% | 538,000 -14.74% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (250,000) | (515,000) | |||||||
BB yield | 2.51% | 4.68% | |||||||
Debt | |||||||||
Debt current | 490,000 | 182,000 | |||||||
Long-term debt | 2,637,000 | 1,663,000 | |||||||
Deferred revenue | 9,000 | 8,000 | |||||||
Other long-term liabilities | 427,000 | 353,000 | |||||||
Net debt | 2,732,000 | 1,567,000 | |||||||
Cash flow | |||||||||
Cash from operating activities | 500,000 | 602,000 | |||||||
CAPEX | (147,000) | (96,000) | |||||||
Cash from investing activities | (1,135,000) | (276,000) | |||||||
Cash from financing activities | 701,000 | (315,000) | |||||||
FCF | 3,153,000 | 3,413,525 | |||||||
Balance | |||||||||
Cash | 171,000 | 117,000 | |||||||
Long term investments | 224,000 | 161,000 | |||||||
Excess cash | |||||||||
Stockholders' equity | 5,153,000 | 4,671,000 | |||||||
Invested Capital | 8,326,000 | 6,397,000 | |||||||
ROIC | 50.82% | 58.44% | |||||||
ROCE | 46.07% | 59.55% | |||||||
EV | |||||||||
Common stock shares outstanding | 131,748 | 137,756 | |||||||
Price | 75.71 -5.21% | 79.87 6.59% | |||||||
Market cap | 9,974,654 -9.34% | 11,002,545 3.57% | |||||||
EV | 14,204,654 | 13,794,545 | |||||||
EBITDA | 4,109,000 | 4,043,000 | |||||||
EV/EBITDA | 3.46 | 3.41 | |||||||
Interest | 87,000 | 44,000 | |||||||
Interest/NOPBT | 2.25% | 1.15% |